Colistin Therapy for Urinary Tract Infections Due to Multidrug-Resistant Bacteria: Experience at a Tertiary Academic Medical Center.

Saved in:
Bibliographic Details
Title: Colistin Therapy for Urinary Tract Infections Due to Multidrug-Resistant Bacteria: Experience at a Tertiary Academic Medical Center.
Authors: Aldairem A; Department of Pharmacy Practice, College of Pharmacy, King Saud Bin Abdulaziz University for Health Sciences (KSAU-HS), Riyadh, Saudi Arabia.; King Abdullah International Medical Research Center (KAIMRC), Riyadh, Saudi Arabia.; Department of Pharmaceutical Care, King Abdulaziz Medical City (KAMC), Ministry of National Guard-Health Affairs, Riyadh, Saudi Arabia., Alowais SA; Department of Pharmacy Practice, College of Pharmacy, King Saud Bin Abdulaziz University for Health Sciences (KSAU-HS), Riyadh, Saudi Arabia.; King Abdullah International Medical Research Center (KAIMRC), Riyadh, Saudi Arabia.; Department of Pharmaceutical Care, King Abdulaziz Medical City (KAMC), Ministry of National Guard-Health Affairs, Riyadh, Saudi Arabia., Alshaya AI; Department of Pharmacy Practice, College of Pharmacy, King Saud Bin Abdulaziz University for Health Sciences (KSAU-HS), Riyadh, Saudi Arabia.; Department of Pharmaceutical Care, King Abdulaziz Medical City (KAMC), Ministry of National Guard-Health Affairs, Riyadh, Saudi Arabia.; Collaboration and Partnerships Department, King Abdullah International Medical Research Center (KAIMRC), Riyadh, Saudi Arabia., Alrashed M; Department of Pharmacy Practice, College of Pharmacy, King Saud Bin Abdulaziz University for Health Sciences (KSAU-HS), Riyadh, Saudi Arabia.; King Abdullah International Medical Research Center (KAIMRC), Riyadh, Saudi Arabia.; Department of Pharmaceutical Care, King Abdulaziz Medical City (KAMC), Ministry of National Guard-Health Affairs, Riyadh, Saudi Arabia., Alqahtani T; King Abdullah International Medical Research Center (KAIMRC), Riyadh, Saudi Arabia.; College of Pharmacy, Department of Pharmaceutical Sciences, King Saud Bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia.; Department of Preclinical Studies, Benefit and Risk Assessment Executive Directorate, Drug Sector, Saudi Food and Drug Authority (SFDA), Riyadh, Saudi Arabia., Alharbi L; College of Pharmacy, King Saud Bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia., Alshehri R; Department of Pharmaceutical Care, King Abdulaziz Medical City (KAMC), Ministry of National Guard-Health Affairs, Riyadh, Saudi Arabia., Al Dughaish ST; Clinical Pharmacy Department, King Khaled Eye Specialist Hospital, Riyadh, Saudi Arabia., Alenazi A; College of Pharmacy, King Saud Bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia., Bin Saleh K; Department of Pharmacy Practice, College of Pharmacy, King Saud Bin Abdulaziz University for Health Sciences (KSAU-HS), Riyadh, Saudi Arabia.; King Abdullah International Medical Research Center (KAIMRC), Riyadh, Saudi Arabia.; Department of Pharmaceutical Care, King Abdulaziz Medical City (KAMC), Ministry of National Guard-Health Affairs, Riyadh, Saudi Arabia.
Source: Infection and drug resistance [Infect Drug Resist] 2026 May 25; Vol. 19, pp. 608721. Date of Electronic Publication: 2026 May 25 (Print Publication: 2026).
Publication Type: Journal Article
Journal Info: Publisher: Dove Medical Press Country of Publication: New Zealand NLM ID: 101550216 Publication Model: eCollection Cited Medium: Print ISSN: 1178-6973 (Print) Linking ISSN: 11786973 NLM ISO Abbreviation: Infect Drug Resist Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 42222029
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Colistin Therapy for Urinary Tract Infections Due to Multidrug-Resistant Bacteria: Experience at a Tertiary Academic Medical Center.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Aldairem+A%22">Aldairem A</searchLink>; Department of Pharmacy Practice, College of Pharmacy, King Saud Bin Abdulaziz University for Health Sciences (KSAU-HS), Riyadh, Saudi Arabia.; King Abdullah International Medical Research Center (KAIMRC), Riyadh, Saudi Arabia.; Department of Pharmaceutical Care, King Abdulaziz Medical City (KAMC), Ministry of National Guard-Health Affairs, Riyadh, Saudi Arabia.<br /><searchLink fieldCode="AU" term="%22Alowais+SA%22">Alowais SA</searchLink>; Department of Pharmacy Practice, College of Pharmacy, King Saud Bin Abdulaziz University for Health Sciences (KSAU-HS), Riyadh, Saudi Arabia.; King Abdullah International Medical Research Center (KAIMRC), Riyadh, Saudi Arabia.; Department of Pharmaceutical Care, King Abdulaziz Medical City (KAMC), Ministry of National Guard-Health Affairs, Riyadh, Saudi Arabia.<br /><searchLink fieldCode="AU" term="%22Alshaya+AI%22">Alshaya AI</searchLink>; Department of Pharmacy Practice, College of Pharmacy, King Saud Bin Abdulaziz University for Health Sciences (KSAU-HS), Riyadh, Saudi Arabia.; Department of Pharmaceutical Care, King Abdulaziz Medical City (KAMC), Ministry of National Guard-Health Affairs, Riyadh, Saudi Arabia.; Collaboration and Partnerships Department, King Abdullah International Medical Research Center (KAIMRC), Riyadh, Saudi Arabia.<br /><searchLink fieldCode="AU" term="%22Alrashed+M%22">Alrashed M</searchLink>; Department of Pharmacy Practice, College of Pharmacy, King Saud Bin Abdulaziz University for Health Sciences (KSAU-HS), Riyadh, Saudi Arabia.; King Abdullah International Medical Research Center (KAIMRC), Riyadh, Saudi Arabia.; Department of Pharmaceutical Care, King Abdulaziz Medical City (KAMC), Ministry of National Guard-Health Affairs, Riyadh, Saudi Arabia.<br /><searchLink fieldCode="AU" term="%22Alqahtani+T%22">Alqahtani T</searchLink>; King Abdullah International Medical Research Center (KAIMRC), Riyadh, Saudi Arabia.; College of Pharmacy, Department of Pharmaceutical Sciences, King Saud Bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia.; Department of Preclinical Studies, Benefit and Risk Assessment Executive Directorate, Drug Sector, Saudi Food and Drug Authority (SFDA), Riyadh, Saudi Arabia.<br /><searchLink fieldCode="AU" term="%22Alharbi+L%22">Alharbi L</searchLink>; College of Pharmacy, King Saud Bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia.<br /><searchLink fieldCode="AU" term="%22Alshehri+R%22">Alshehri R</searchLink>; Department of Pharmaceutical Care, King Abdulaziz Medical City (KAMC), Ministry of National Guard-Health Affairs, Riyadh, Saudi Arabia.<br /><searchLink fieldCode="AU" term="%22Al+Dughaish+ST%22">Al Dughaish ST</searchLink>; Clinical Pharmacy Department, King Khaled Eye Specialist Hospital, Riyadh, Saudi Arabia.<br /><searchLink fieldCode="AU" term="%22Alenazi+A%22">Alenazi A</searchLink>; College of Pharmacy, King Saud Bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia.<br /><searchLink fieldCode="AU" term="%22Bin+Saleh+K%22">Bin Saleh K</searchLink>; Department of Pharmacy Practice, College of Pharmacy, King Saud Bin Abdulaziz University for Health Sciences (KSAU-HS), Riyadh, Saudi Arabia.; King Abdullah International Medical Research Center (KAIMRC), Riyadh, Saudi Arabia.; Department of Pharmaceutical Care, King Abdulaziz Medical City (KAMC), Ministry of National Guard-Health Affairs, Riyadh, Saudi Arabia.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101550216%22">Infection and drug resistance</searchLink> [Infect Drug Resist] 2026 May 25; Vol. 19, pp. 608721. <i>Date of Electronic Publication: </i>2026 May 25 (<i>Print Publication: </i>2026).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Dove+Medical+Press%22">Dove Medical Press </searchLink><i>Country of Publication: </i>New Zealand <i>NLM ID: </i>101550216 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Print <i>ISSN: </i>1178-6973 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2211786973%22">11786973 </searchLink><i>NLM ISO Abbreviation: </i>Infect Drug Resist <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42222029
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.2147/IDR.S608721
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 608721
    Titles:
      – TitleFull: Colistin Therapy for Urinary Tract Infections Due to Multidrug-Resistant Bacteria: Experience at a Tertiary Academic Medical Center.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Aldairem A
      – PersonEntity:
          Name:
            NameFull: Alowais SA
      – PersonEntity:
          Name:
            NameFull: Alshaya AI
      – PersonEntity:
          Name:
            NameFull: Alrashed M
      – PersonEntity:
          Name:
            NameFull: Alqahtani T
      – PersonEntity:
          Name:
            NameFull: Alharbi L
      – PersonEntity:
          Name:
            NameFull: Alshehri R
      – PersonEntity:
          Name:
            NameFull: Al Dughaish ST
      – PersonEntity:
          Name:
            NameFull: Alenazi A
      – PersonEntity:
          Name:
            NameFull: Bin Saleh K
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 25
              M: 05
              Text: 2026 May 25
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-print
              Value: 1178-6973
          Numbering:
            – Type: volume
              Value: 19
          Titles:
            – TitleFull: Infection and drug resistance
              Type: main
ResultId 1